Transgene S.A.
TRGNF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$19,295 | -$17,486 | -$16,485 | -$6,426 |
| Dep. & Amort. | $666 | $675 | $606 | $772 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $416 | $568 | $0 | $296 |
| Change in WC | $1,056 | $13,618 | -$2,865 | -$916 |
| Other Non-Cash | -$789 | -$2,790 | $611 | -$10,736 |
| Operating Cash Flow | -$17,946 | -$5,415 | -$18,133 | -$17,010 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$279 | -$1,062 | -$2,013 | -$1,265 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $35,976 |
| Other Inv. Act. | -$314 | -$698 | $567 | $17,938 |
| Investing Cash Flow | -$593 | -$1,760 | -$1,446 | $16,673 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $20,283 | $28,650 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$239 | -$20,524 | $18,833 | $25,162 |
| Financing Cash Flow | $20,044 | $8,126 | $18,833 | $12,283 |
| Forex Effect | -$1,402 | $399 | $400 | $0 |
| Net Chg. in Cash | $16,772 | $1,350 | -$346 | $11,946 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $15,320 | $15,666 | $3,720 |
| End Cash | $16,772 | $16,670 | $15,320 | $15,666 |
| Free Cash Flow | -$18,225 | -$6,486 | -$20,137 | -$18,275 |